SLC7A11-HSPB1 axis: A novel mechanism for hepatocellular carcinoma progression and ferroptosis regulation
Open Access
- 6 May 2025
- journal article
- Published by Elsevier in Biomedical Journal
- Vol. 49 (1) , 100869
Abstract
No abstract availableKeywords
Funding Information
- Shanghai Jiao Tong University (23X010502168)
- Shanghai Jiao Tong University (YG2022QN070)
- Fundamental Research Funds for the Central Universities (KLSB2022QN-01)
- Fundamental Research Funds for the Central Universities (KLSB2024KF-06)
- Science and Technology Innovation Plan Of Shanghai Science and Technology Commission (22YF1420500)
This publication has 52 references indexed in Scilit:
- Bile-Derived cfDNA of Syncytin-1 and SLC7A11 as a Potential Molecular Marker for Early Diagnosis of CholangiocarcinomaJournal of Gastrointestinal Cancer, 2025
- Sample Preparation for Transmission Electron Microscopy2018
- Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cellsBiochemical and Biophysical Research Communications, 2017
- Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic TargetCancer Cell, 2013
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinomaCancer Letters, 2011
- Quantitation of Plasma Circulating DNA Using Quantitative PCR for the Detection of Hepatocellular CarcinomaPathology and Oncology Research, 2011
- Doxorubicin Plus Sorafenib vs Doxorubicin Alone in Patients With Advanced Hepatocellular CarcinomaJAMA, 2010
- xCT modulation in gliomas: Relevance to energy metabolism and tumor microenvironment normalizationAnnals of Anatomy - Anatomischer Anzeiger, 2010
- sHsps and their role in the chaperone networkCellular and Molecular Life Sciences, 2002